DOI:
10.1055/s-00029030
Journal of Pediatric Neurology
LinksClose Window
References
Kalinichev M, Girard F, Haddouk H. et al.
The drug candidate, ADX71441, is a novel, potent and selective positive allosteric modulator of the GABAB receptor with a potential for treatment of anxiety, pain and spasticity.
Neuropharmacology 2017;
114: 34-47
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.